| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |